免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With

NCT:NCT07819474 · NOT_YET_RECRUITING

NCT编号NCT07819474
状态NOT_YET_RECRUITING
开始日期2027-02-18
完成时间2030-08-31
SponsorM.D. Anderson Cancer Center (OTHER)
First posted
Last updated

简要摘要

To find out if the amount of CD8 immune cells at the place where TIL cells are collected is linked to how well a patient responds to treatment.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑